Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO

Aziyo Biologics, Inc., a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced Aziyo co-founder C. Randal (Randy) Mills, Ph.D., has been appointed interim president and CEO.